Restless legs syndrome: relationship between prevalence and latitude
Restless legs syndrome (RLS) has a broad worldwide prevalence between 0.01% and 18.3%. While differences in RLS definitions and data ascertainment methods account for some variability, other factors likely contribute. The circadian nature of RLS and the fact that RLS symptoms track with endogenous melatonin levels suggest that light or ultraviolet radiation (UVR) may be related to RLS expression. As the amount of UVR decreases with latitude, we considered the potential effect of geography on RLS prevalence with the thought being that RLS prevalence rises with increasing latitude.
RLS epidemiologic studies were sought via Pubmed search in the period between January 1, 1992 and November 15, 2010. Prevalence was mapped for each country or specific region studied and examined by continent. Pearson’s correlational testing was carried out for RLS prevalence and latitude of the region studied.
Global RLS prevalence ranges from 0.01% in Africa, 0.7% to 12.5% in Asia, 2.0% to 18.9% in the Americas, and 3.2% to 18.3% in Europe. Mapping RLS prevalence by country or region in both the Americas and in Europe suggests increasing RLS frequency with greater northern latitude. RLS prevalence is positively correlated with northern latitude in both North America and Europe with correlation coefficients of r = 0.77 (0.15, 0.96; p = 0.02) and r = 0.74 (0.44, 0.89; p = 0.0002), respectively. In Europe, lower latitudinal countries like Greece and Turkey had RLS prevalence (per 1,000 persons) of 38 and 34, respectively, middle latitudinal countries like France and England of 108 and 86, respectively, and high latitudinal countries like Norway and Iceland of 143 and 183, respectively.
RLS epidemiology indicates an increase in RLS frequency in northern latitudinal countries as a function of distance from the equator, an effect most evident in Europe. This suggests that factors that track with latitude like UVR may be involved in the expression of RLS.
KeywordsRestless legs syndrome Epidemiology Prevalence Latitude
- 2.Benediktsdottir B, Janson C, Lindberg E, Arnardóttir ES, Olafsson I, Cook E, Thorarinsdottir EH, Gislason T (2010) Prevalence of restless legs syndrome among adults in Iceland and Sweden: lung function, comorbidity, ferritin, biomarkers and quality of life. Sleep Med 11:1043–1048CrossRefGoogle Scholar
- 14.Cho SJ, Hong JP, Hahm BJ, Jeon HJ, Chang SM, Cho MJ, Lee HB (2009) Restless legs syndrome in a community sample of Korean adults: prevalence, impact on quality of life, and association with DSM-IV psychiatric disorders. Sleep 32:1069–1076Google Scholar
- 16.Cho YW, Shin WC, Yun CH, Hong SB, Kim JH, Allen RP, Earley CJ (2008) Epidemiology of restless legs syndrome in Korean adults. Sleep 31:219–223Google Scholar
- 18.Miranda M, Araya F, Castillo JL, Duran C, Gonzalez F, Arıs L (2001) Restless legs syndrome: a clinical study in adult general population and in uremic patients. Rev Med Chil 129:179–186Google Scholar
- 26.Froese CL, Butt A, Mulgrew A, Cheema R, Speirs MA, Gosnell C, Fleming J, Fleetham J, Ryan CF, Ayas NT (2008) Depression and sleep-related symptoms in an adult, indigenous, North American population. J Clin Sleep Med 4:356–361Google Scholar
- 27.Lavigne GJ, Montplaisir JY (1994) Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 17:739–743Google Scholar
- 28.Hadjigeorgiou GM, Stefanidis I, Dardiotis E, Aggellakis K, Sakkas GK, Xiromerisiou G, Konitsiotis S, Paterakis K, Poultsidi A, Tsimourtou V, Ralli S, Gourgoulianis K, Zintzaras E (2007) Low RLS prevalence and awareness in central Greece: an epidemiological survey. Eur J Neurol 14:1275–1280CrossRefGoogle Scholar
- 30.Sevim S, Dogu O, Kaleagasi H, Aral M, Metin O, Camdeviren H (2004) Correlation of anxiety and depression symptoms in patients with restless legs syndrome: a population based survey. J Neurol Neurosurg Psych 75:226–230Google Scholar
- 33.Vogl FD, Pichler I, Adel S, Pinggera GK, Bracco S, De Grandi A, Volpato CB, Aridon P, Mayer T, Meitinger T, Klein C, Casari G, Pramstaller PP (2006) Restless legs syndrome: epidemiological and clinicogenetic study in a South Tyrolean population isolate. Mov Disorder 21:1189–1195CrossRefGoogle Scholar
- 42.Levin LI, Munger KL, O’Reilly EJ, Falk KI, Ascherio A (2010) Primary infection with the Epstein–Barr virus and risk of multiple sclerosis. Ann Neurol 67:824–830Google Scholar
- 43.Scharffetter-Kochanek K, Wlaschek M, Brenneisen P, Schauen M, Blaudschun R, Wenk J (1997) UV-induced reactive oxygen species in photocarcinogenesis and photoaging. Biol Chem 378:1247–1257Google Scholar
- 52.Bartelt RN, Altmeyer P, Stöhr L, Chilf GN, Holzmann H (1984) Effect of ultraviolet rays on alpha-MSH plasma concentration. Z Hautkr 59(16):1053–1055Google Scholar
- 54.Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J (2003) Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4:101–119CrossRefGoogle Scholar